Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Study - GMMG-HD 6 - Lenalidomide 10 / Dexamethasone 12 / Elotuzumab 10, Multiple Myeloma, Maintenance Cycle 1-6

Protocol-ID: 1092 V1.1 (Mini), STUDY-GMMG-HD6 - LENA10/DEXA12/ELOT10, MM, maint. A2 + B2, C1-6
Study protocol, available to authorized participants only.

Indication(s)

  • Multiple Myeloma; ICD-10 C90.-, C90.0-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 10.03.2020